Advertisement

New Pharma Vs. Big Pharma In 'The Antidote'

15:08
Download Audio
Resume

In 1989, rising star Joshua Boger left his job at the world's second-biggest-selling drug company, Merck Pharmaceuticals, to form his own pharma company in a refitted garage in Cambridge. Vertex Pharmaceuticals was born, but at the time, it was thought to be nothing more than a pipe dream.

Journalist Barry Werth captured the company's early days in his 1994 book, "The Billion Dollar Molecule." 20 years, two large-scale drug launches, and two towers on Boston's waterfront later, Werth takes a new look at Vertex and its place in the $325 billion prescription drug industry in his sequel, "The Antidote: Inside the World of New Pharma."

Barry will be speaking at the MIT Media Lab this Thursday, March 20 at 5 p.m.

Guest

Barry Werth, award-winning journalist and author of several books, including "The Antidote: Inside the World of New Pharma."

More

The Boston Globe: Companies Setting Aside Space For Startups

  • "Demolition began last month to clear the way for a 30,000-square-foot expansion at the headquarters of Constant Contact, a digital marketing firm in Waltham. But the new space won’t just house Constant Contact employees. The new 'InnoLoft' will invite a handful of startups developing new products for small businesses to shack up for four month stretches, rent free."

CNN Money: What Ails Big Pharma

  • "One of America's most far-seeing companies, Vertex Pharmaceuticals, the biopharmaceutical startup so memorably chronicled in journalist Barry Werth's classic book, The Billion Dollar Molecule: The Quest for the Perfect Drug, is back."

WBUR: Biotech Firm Vertex To Cut 175 Jobs In Mass.

  • "Vertex Pharmaceuticals says it plans to eliminate about 15 percent of its worldwide workforce, including about 175 positions in Massachusetts."

This segment aired on March 19, 2014.

Advertisement

More from Radio Boston

Listen Live
Close